Recently it has become possible to evaluate the pituitary function more precisely by using some stimulators which release pituitary hormone. There are two kinds of stimulators; one is materials which act on the hypothalamus resulting in pituitary hormone release and the other is those to stimulate the pituitary directly. The former is considered to be arginine or insulin etc. which indirectly stimulate GH secretion and the latter is synthetic thyrotropin releasing hormone (TRH) which directly stimulates the pituitary to release thyrotropin (TSH).
At the middle of 1971, it was proposed that an amino acid sequence of porcine luteinizing hormone-releasing hormone (LH-RH) as (pyro)-Glu-His-Trp-Ser-Tyr-Gly-LeuArg-Pro-Gly-NH, Matsuo et al., 1971) . Yanaihara, one of the authors, synthesized LH-RH using a step-bystep method of polypeptide synthesis, which gave us an opportunity to evaluate the effects of this synthetic material in man.
In order to do this, three kinds of approaches were undertaken. First, the release of the pituitary gonadotropin following LH-RH administration was determined by measuring plasma levels of luteinizing hormone (LH) and follicle stimulating hormone (FSH) in normal subjects. Second, the effects of LH-RH administration on the other pituitary hormones were studied by measuring plasma GH and TSH levels. And third, the diagnostic usefulness to test pituitary reserve was studied by determing plasma LH and FSH levels following LH-RH injection in patients with endocrine or metabolic disorders. In a patient with postadrenalectomy Cushing's disease (Nelson's syndrome), who had been receiving 30mg cortisol daily, there observed a significant increase in plasma LH levels and a slight increase in plasma FSH levels in response to synthetic LH-RH.
In a patient with idiopathic diabetes insipidus who was under the treatment of 250mg chlorpropamide per day, the plasma LH and FSH responses to synthetic LH-RH were moderate.
In 2 young females, one with obesity and the other with amenorrhea due to hypochromic anemia, plasma LH and FSH were responded to the synthetic LH-RH administration as normal subjects.
A patient with idiopathic hypoparathyroidism and a patient with hyperthyroidism showed a normal plasma LH and FSH increase in response to synthetic LH-RH.
A postmenopausal patient with primary hypothyroidism aged 49 showed high initial plasma levels of LH and FSH, which were (Odell et al., 1967 (Odell et al., , 1968 Ryan et al., 1970) Our data obtained from patients with endocrine or metabolic disorders clearly indicate that synthetic LH-RH is a good material to differentiate those with pituitary failure from the others.
It should be mentioned here that a patient with idiopathic hypopituitarism showed a normal increase in plasma LH and FSH in respone to the synthetic LH-RH administration. Since he failed to respond to metyrapone, arginine and TRH, this case was diagnosed to have a partial hypopituitarism. These data suggest that the pituitary function should be examined for individual pituitary hormone by employing a proper stimulus to each as we mentioned elsewhere .
It is interesting that the cases with high initial LH and FSH values were responded well to synthetic LH-RH and their responses usually lasted longer. The similar situation has been reported in patients with primary hypothyroidism, who had high plasma TSH levels which were responded markedly and prolongedly to the administration of synthetic TRH (Hershman and Pittman, 1970; Saito et al., 1971; Gual et al., 1972) . These data may suggest that the pituitary of these patients is working actively to release excessive amount of hormone, which makes it susceptive to the administration of releasing hormones.
It has been reported that a highly purified LH-RH caused a significant increase in plasma LH and FSH values (Kastin et al., 1969 ) and the present study employed synthetic LH-RH again demonstrated that LH-RH released FSH as well as LH, even though the response of FSH was less as compared with that of LH, supporting a view that LH-RH has an intrinsic activity of FSH-RH (Schally et al., 1917a (Schally et al., , 1971b Kastin et al., 1971) .
We 
